🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Dow Jumps Over 150 Points; US Foods Posts Upbeat Earnings

Published 09/05/2024, 17:01
Updated 09/05/2024, 18:10
© Reuters.  Dow Jumps Over 150 Points; US Foods Posts Upbeat Earnings
UK100
-
US500
-
STOXX50
-
HK50
-
DX
-
GC
-
SI
-
IXIC
-
SSEC
-
USFD
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points on Thursday.

The Dow traded up 0.48% to 39,244.53 while the NASDAQ rose 0.32% to 16,354.20. The S&P 500 also rose, gaining, 0.37% to 5,206.94 .

Check This Out: Roblox, Beyond Meat And 3 Stocks To Watch Heading Into Thursday

Leading and Lagging Sectors

Real estate shares rose by 1.7% on Thursday.

In trading on Thursday, information technology shares fell by 0.2%.

Top Headline

US Foods Holding Corp (NYSE:USFD) posted better-than-expected first-quarter financial results on Thursday.

US Foods reported first-quarter FY24 sales growth of 4.8% year-on-year to $8.95 billion, beating the analyst consensus estimate of $8.91 billion. Adjusted EPS was 54 cents, beating the consensus estimate of 53 cents.

Equities Trading UP

  • Pop Culture Group Co., Ltd (NASDAQ:CPOP) shares shot up 79% to $3.0199 after the company reported a year-over-year increase in H2 2023 revenue results.
  • Shares of Sezzle Inc. (NASDAQ:SEZL) got a boost, surging 76% to $78.80 after the company reported a year-over-year increase in first-quarter financial results.
  • Consensus Cloud Solutions, Inc. (NASDAQ:CCSI) shares were also up, gaining 37% to $18.15 following better-than-expected first-quarter results.
Equities Trading DOWN

  • Tivic Health Systems, Inc. (NASDAQ:TIVC) shares dropped 60% to $0.5344 after the company reported pricing of $4 million public offering.
  • Shares of EMCORE Corporation (NASDAQ:EMKR) were down 62% to $1.1099 after the company reported mixed second-quarter financial results and issued third-quarter revenue guidance below estimates.
  • CytomX Therapeutics, Inc. (NASDAQ:CTMX) was down, falling 43% to $2.3850 after the company reported first-quarter financial results and announced initial data from the ongoing CX-904 Phase 1a dose escalation clinical study, demonstrating a favorable safety profile and confirmed anti-cancer activity.
Also Check This Out: Top 5 Tech Stocks That Could Lead To Your Biggest Gains This Month

Commodities

In commodity news, oil traded up 0.3% to $79.26 while gold traded up 0.8% at $2,340.50.

Silver traded up 2.7% to $28.35 on Thursday, while copper rose 0.4% to $4.5625.

Euro zone

European shares were mostly higher today. The eurozone's STOXX 600 rose 0.25%, Germany's DAX rose 1.04% and France's CAC 40 gained 0.66%. Spain's IBEX 35 Index fell 0.89%, while London's FTSE 100 rose 0.50%.

The Bank of England held the key bank rate at 5.25% during its latest meeting.

Asia Pacific Markets

Asian markets closed mixed on Thursday, with Japan's Nikkei falling 0.34%, China's Composite Index gaining 1.22%, Hong Kong's Hang Seng Index gaining 0.83% and India's S&P BSE Sensex falling 1.4%.

The index of leading economic indicators in Japan fell to 111.4 in March 2024 versus a revised reading of 112.1 in the prior month, while index of coincident economic indicators climbed to 113.9 in March versus a final level of 111.5 a month ago.

Chinese trade surplus shrank to $72.35 billion in April from $86.46 billion in the year-ago period a year earlier. Imports to China rose by 8.4%, while exports from China gained 1.5% year-over-year in April.

Economics

  • U.S. initial jobless claims increased by 22,000 to 231,000 on the week ending May 4, higher than market estimates of 210,000.
  • U.S. natural-gas supplies increased 79 billion cubic feet during the week ended May 3, compared to market estimates of a 87 billion cubic feet gain.
Now Read This: Comstock And 2 Other Stocks Under $3 Insiders Are Buying

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.